drugset / Trial / NCT01129531
A Study of the Safety and Efficacy of AGN-214868 in Patients With Postherpetic Neuralgia
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will evaluate the safety and efficacy of AGN-214868 in patients with postherpetic neuralgia (PHN) - nerve pain.
Timeline
- Start
- 2010-06
- Primary completion
- 2011-10
- Completion
- 2012-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SENREBOTASE | Protein / enzyme biologic | 3.25 ug | Other |
| Subject | SENREBOTASE | Protein / enzyme biologic | 16.25 ug | Other |